Abstract
Purpose:
Activation of Hedgehog (Hh) signaling has been implicated in early stages of bladder cancer development while loss of Hh signaling has been described during progression to more invasive disease. Itraconazole, an antifungal, is the only azole known to be a potent Hh pathway antagonist. We evaluated whether itraconazole use is associated with bladder cancer risk or progression.
Materials and Methods:
We performed a case-control study nested in a United Kingdom database in 13,440 bladder cancer cases and 52,421 matched controls between 1995 and 2013. The use of itraconazole and other azoles was measured as the number of prescriptions. Conditional logistic regression was used for estimated AORs and the 95% CI of the association of bladder cancer with ever use and an increasing number of itraconazole prescriptions. Logistic regression was done to determine whether itraconazole use in patients diagnosed with bladder cancer was associated with invasive bladder cancer requiring cystectomy relative to the use of other azoles.
Results:
Itraconazole was not associated with the risk of bladder cancer relative to never use (ever use AOR 0.89, 95% CI 0.70–1.14 and 4 or more prescriptions AOR 0.87, 95% CI 0.42–1.81). However, among patients diagnosed with bladder cancer there was a significantly increased risk of bladder cancer requiring cystectomy with itraconazole use (ever use AOR 2.05, 95% CI 1.12–3.38 and 2 or more prescriptions AOR 2.30, 95% CI 1.12–4.72).
Conclusions:
Inhibition of the Hh pathway with itraconazole was not associated with a risk of bladder cancer overall but it was associated with a higher risk of invasive bladder cancer requiring cystectomy. These data provide clinical evidence supporting the role of Hh signaling in regulating bladder cancer progression.
References
- 1 : Hedgehog: functions and mechanisms. Genes Dev2008; 22: 2454. Google Scholar
- 2 : Hedgehog pathway activation in human transitional cell carcinoma of the bladder. Br J Cancer2012; 106: 1177. Google Scholar
- 3 : Outcome of rupture and complete perforation of the unoperated rotator cuff of the shoulder. Rev Rhum Mal Osteoartic1989; 56: 815. Google Scholar
- 4 : Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma. Nat Cell Biol2014; 16: 469. Google Scholar
- 5 : Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors. Cancer Cell2014; 26: 521. Google Scholar
- 6 : Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell2010; 17: 388. Google Scholar
- 7 : Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc Natl Acad Sci U S A2010; 107: 4764. Google Scholar
- 8 : The Read clinical classification. BMJ1990; 300: 1092. Google Scholar
- 9 : Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care2004; 12: 171. Google Scholar
- 10 : Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care2011; 19: 251. Google Scholar
- 11 : Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf2007; 16: 393. Google Scholar
- 12 : Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas. Diabetes Care2014; 37: 1910. Google Scholar
- 13 : Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst2012; 104: 1411. Google Scholar
- 14 : Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol2005; 5: 5. Google Scholar
- 15 : Validation of a coding algorithm to identify bladder cancer and distinguish stage in an electronic medical records database. Cancer Epidemiol Biomarkers Prev2015; 24: 303. Google Scholar
- 16 : Distinguishing incident and prevalent diabetes in an electronic medical records database. Pharmacoepidemiol Drug Saf2014; 23: 111. Google Scholar
- 17 : Biased selection of controls for case-control analyses of cohort studies. Biometrics1984; 40: 63. Google Scholar
- 18 : Re: The impact of confounder selection criteria on effect estimation. Am J Epidemiol1989; 130: 1066. Google Scholar
- 19 : Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer. Cancer2005; 104: 1918. Google Scholar
- 20 DataPharm: Sporanox Capsules. Available at http://www.medicines.org.uk/emc/medicine/7395. Accessed December 21, 2015. Google Scholar
- 21 : Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer. Oncologist2013; 18: 163. Google Scholar
- 22 : Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc Natl Acad Sci U S A2014; 111: E3091. Google Scholar
- 23 : New cast for a new era: preclinical cancer drug development revisited. J Clin Invest2013; 123: 3639. Google Scholar
- 24 : Hedgehog signaling pathway and cancer therapeutics: progress to date. Drugs2013; 73: 613. Google Scholar
- 25 : Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?. J Urol2001; 166: 1296. Link, Google Scholar
- 26 : Bias due to misclassification in the estimation of relative risk. Am J Epidemiol1977; 105: 488. Google Scholar
- 27 : Oral azole drugs as systemic antifungal therapy. N Engl J Med1994; 330: 263. Google Scholar
- 28 : The effect of immunosuppression on pre-existing cancers. Transplantation1993; 55: 742. Crossref, Medline, Google Scholar
